Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NEBIVOLOL 10 MG TABLET

NEBIVOLOL
$0.1364per EA

Strength

10 mg/1

Manufacturer

Novadoz Pharmaceuticals LLC

NDC

72205015290

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

NEBIVOLOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA217397

On Market Since

10/1/2024

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price History

1W

0.0%

1M

+1.8%

3M

-1.7%

6M

-0.6%

1Y

N/A

3Y

N/A

5Y

N/A

All

-11.8%

Generic Alternatives

1 alternative • Same active ingredient

NEBIVOLOL 10 MG TABLET
Generic
72205015230•Novadoz Pharmaceuticals LLC
$0.1364

Related Drugs

Same classification

METOPROLOL TARTRATE 25 MG TAB
Generic
00378001801•Mylan Pharmaceuticals Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
00378001805•Mylan Pharmaceuticals Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
51079025520•Mylan Institutional LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817025000•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817025010•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817036000•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817036010•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
57237010001•Rising Pharma Holdings Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
57237010099•Rising Pharma Holdings Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
62332011231•Alembic Pharmaceuticals Inc.
$0.0171
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy